N
0.866
0.00 (0.44%)
| Penutupan Terdahulu | 0.862 |
| Buka | 0.880 |
| Jumlah Dagangan | 327,603 |
| Purata Dagangan (3B) | 265,742 |
| Modal Pasaran | 109,380,232 |
| Harga / Buku (P/B) | 1.55 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 28 Oct 2025 |
| EPS Cair (TTM) | -0.540 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 15.09% |
| Nisbah Semasa (MRQ) | 17.36 |
| Aliran Tunai Operasi (OCF TTM) | -56.82 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -34.19 M |
| Pulangan Atas Aset (ROA TTM) | -19.06% |
| Pulangan Atas Ekuiti (ROE TTM) | -30.93% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Nautilus Biotechnology, Inc. | Bercampur | Menurun |
AISkor Stockmoo
-0.2
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 4.0 |
| Purata | -0.17 |
|
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 33.38% |
| % Dimiliki oleh Institusi | 48.76% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Madrona Venture Group, Llc | 30 Jun 2025 | 6,020,770 |
| Clarius Group, Llc | 30 Jun 2025 | 1,060,460 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 03 Nov 2025 | Pengumuman | Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging |
| 28 Oct 2025 | Pengumuman | Nautilus Biotechnology Reports Third Quarter 2025 Financial Results |
| 07 Oct 2025 | Pengumuman | Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025 |
| 16 Sep 2025 | Pengumuman | Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |